Estimating benefits of therapy in Crohn's disease in terms of indirect costs.
作者信息
Ghosh Subrata
出版信息
Can J Gastroenterol. 2011 Aug;25(8):412. doi: 10.1155/2011/310417.
Abstract
摘要
相似文献
1
Estimating benefits of therapy in Crohn's disease in terms of indirect costs.从间接成本角度评估克罗恩病治疗的效益。
Can J Gastroenterol. 2011 Aug;25(8):412. doi: 10.1155/2011/310417.
2
Indirect health costs in ulcerative colitis and Crohn's disease: a systematic review and meta-analysis.溃疡性结肠炎和克罗恩病的间接健康成本：一项系统评价和荟萃分析。
Expert Rev Pharmacoecon Outcomes Res. 2015 Apr;15(2):253-66. doi: 10.1586/14737167.2015.1011130. Epub 2015 Feb 6.
3
The burdens imposed by Crohn's disease: messages for clinicians?克罗恩病带来的负担：给临床医生的启示？
Dig Liver Dis. 2003 Dec;35(12):849-50. doi: 10.1016/j.dld.2003.09.002.
4
The cost of paediatric and perianal Crohn's disease in Canterbury, New Zealand.新西兰坎特伯雷地区儿童及肛周克罗恩病的治疗成本
N Z Med J. 2012 Feb 10;125(1349):11-20.
5
Inflammatory bowel disease: medical cost algorithms.炎症性肠病：医疗费用算法
J Clin Gastroenterol. 1992 Jun;14(4):318-27. doi: 10.1097/00004836-199206000-00010.
6
Cost of illness of Crohn's disease.克罗恩病的疾病成本。
Pharmacoeconomics. 2002;20(10):639-52. doi: 10.2165/00019053-200220100-00001.
7
Cost utility of initial medical management for Crohn's disease perianal fistula.克罗恩病肛周瘘管初始药物治疗的成本效用
Gastroenterology. 2002 Apr;122(4):1187-8; author reply 1188-90. doi: 10.1053/gast.2002.32782.
8
Cost benefit of longterm follow-up of uncomplicated Crohn's disease.非复杂性克罗恩病长期随访的成本效益
Acta Gastroenterol Belg. 1998 Jan-Mar;61(1):11-2.
9
Markov Polo: finding the costs of Crohn's in an Olmstead County pool.马可·波罗：在奥姆斯特德县人群中探究克罗恩病的成本
Inflamm Bowel Dis. 2000 Feb;6(1):64-5. doi: 10.1097/00054725-200002000-00015.
10
Resource use and cost of care with biologicals in Crohn's disease in South Africa: a retrospective analysis from a payer perspective.南非克罗恩病生物制剂的资源使用与护理成本：基于支付方视角的回顾性分析
Int J Clin Pharm. 2016 Aug;38(4):880-7. doi: 10.1007/s11096-016-0304-7. Epub 2016 Apr 27.
引用本文的文献
1
Neutralization of Inflammation by Inhibiting and Secretory Phospholipase A by Ethanol Extract of L.通过抑制L.的分泌型磷脂酶A和[此处原文似乎缺失部分内容]来中和炎症
Pharmacognosy Res. 2017 Apr-Jun;9(2):174-181. doi: 10.4103/0974-8490.204650.
本文引用的文献
1
Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn's DiseaSe (ACCESS) trial.阿达木单抗在加拿大中重度克罗恩病患者中的疗效与安全性：加拿大中重度克罗恩病患者使用阿达木单抗（ACCESS）试验结果
Can J Gastroenterol. 2011 Aug;25(8):419-25. doi: 10.1155/2011/724813.
2
How expensive is inflammatory bowel disease? A critical analysis.炎症性肠病的治疗成本有多高？一项批判性分析。
World J Gastroenterol. 2008 Nov 21;14(43):6641-7. doi: 10.3748/wjg.14.6641.
3
Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.加拿大一所三级护理大学医院中炎症性肠病患者的直接住院费用。
Am J Gastroenterol. 2000 Mar;95(3):677-83. doi: 10.1111/j.1572-0241.2000.01845.x.
Zotero 插件